Toxic nodular goiter and thyroid cancer: Is hyperthyroidism protective against thyroid cancer?

被引:16
作者
Tam, Abbas Ali [1 ]
Ozdemir, Didem [1 ]
Alkan, Afra [2 ]
Yazicioglu, Omer [3 ]
Yildirim, Nilufer [4 ]
Kilicyazgan, Aylin [5 ]
Ersoy, Reyhan [1 ]
Cakir, Bekir [1 ]
机构
[1] Ankara Yildirim Beyazit Univ, Dept Endocrinol & Metab, Fac Med, Ankara, Turkey
[2] Ankara Yildirim Beyazit Univ, Dept Biostat, Fac Med, Ankara, Turkey
[3] Ataturk Training & Res Hosp, Dept Gen Surg, Ankara, Turkey
[4] Ataturk Training & Res Hosp, Dept Nucl Med, Ankara, Turkey
[5] Ankara Yildirim Beyazit Univ, Dept Pathol, Fac Med, Ankara, Turkey
关键词
TSH; DISEASE; RISK; MALIGNANCY; GUIDELINES; PATIENT;
D O I
10.1016/j.surg.2019.03.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The suppressive effect of the increase in thyroid hormone in patients with toxic nodular goiter is thought to protect the extranodular thyroid tissue from thyroid malignancy. In this study, we aimed to evaluate the prevalence and features of thyroid cancer in patients with toxic nodular goiter who underwent thyroidectomy. Methods: Medical data of patients who had solitary toxic or nontoxic nodules and underwent total thyroidectomy were reviewed retrospectively. We reviewed the clinical, laboratory, and histopathologic features of patients with toxic nodular goiter and nontoxic solitary nodules. Results: There were 73 patients with toxic nodular goiter and 366 patients with nontoxic solitary nodules. Median age was greater in the toxic nodular goiter compared with nontoxic solitary nodules patients (50 years; range: 18-73 vs 42 years; range: 18-83, P < .001). Median nodule diameters were 40.9 mm (range: 11.0-98.0) and 23.3 mm (range: 4.9-99.0) in patients with toxic nodular goiter and nontoxic solitary nodules, respectively (P < .001). Histopathologic examination revealed thyroid cancer in 14 patients (19%) with toxic nodular goiter and 132 (36.1%) patients with nontoxic solitary nodules (P = .008). Median tumor diameters were 6 mm (range: 1-50) in toxic nodular goiter and 14 mm (range: 1-80) in nontoxic solitary nodules (P = .150). The malignant nodule was the hyperfunctioning nodule in 7 patients with toxic nodular goiter; 4 were follicular and 3 were papillary thyroid cancer. The other 7 malignant foci were located in the suppressed contralateral lobe, and all were papillary microcarcinomas. The incidence of thyroid cancer outside the main nodule was similar in 2 groups (P = .934). Conclusion: Thyroid cancer in patients operated for toxic nodular goiter was 19%, which is not as rare as previously thought. A careful histopathologic examination of both the hyperfunctioning nodule and the extranodular thyroid tissue might help to disclose an unexpected tumor foci when thyroidectomy is performed in patients with toxic nodular goiter. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:356 / 361
页数:6
相关论文
共 26 条
  • [1] Approach to the Patient with a Cytologically Indeterminate Thyroid Nodule
    Alexander, Erik K.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (11) : 4175 - 4182
  • [2] Survival analysis of 19 patients with toxic thyroid carcinoma
    Als, C
    Gedeon, P
    Rösler, H
    Minder, C
    Netzer, P
    Laissue, JA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) : 4122 - 4127
  • [3] Is ultrasonographically detected nodule diameter concordant with pathological tumor size?
    Bilginer, Muhammet Cuneyt
    Ozdemir, Didem
    Baser, Husniye
    Dogan, Hayriye Tatli
    Yalcin, Abdussamed
    Ersoy, Reyhan
    Cakir, Bekir
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2017, 42 : 95 - 102
  • [4] Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration
    Boelaert, K.
    Horacek, J.
    Holder, R. L.
    Watkinson, J. C.
    Sheppard, M. C.
    Franklyn, J. A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) : 4295 - 4301
  • [5] Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role
    Fiore, E.
    Rago, T.
    Provenzale, M. A.
    Scutari, M.
    Ugolini, C.
    Basolo, F.
    Di Coscio, G.
    Berti, P.
    Grasso, L.
    Elisei, R.
    Pinchera, A.
    Vitti, P.
    [J]. ENDOCRINE-RELATED CANCER, 2009, 16 (04) : 1251 - 1260
  • [6] Serum TSH and Risk of Papillary Thyroid Cancer in Nodular Thyroid Disease
    Fiore, Emilio
    Vitti, Paolo
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (04) : 1134 - 1145
  • [7] Gelmini R, 2010, ANN ITAL CHIR, V81, P421
  • [8] The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma
    Giles, Yasemin
    Fatih, Tunca
    Harika, Boztepe
    Yersu, Kapran
    Tarik, Terzioglu
    Serdar, Tezelman
    [J]. SURGERY, 2008, 144 (06) : 1028 - 1036
  • [9] Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations
    Gudmundsson, Julius
    Sulem, Patrick
    Gudbjartsson, Daniel F.
    Jonasson, Jon G.
    Sigurdsson, Asgeir
    Bergthorsson, Jon T.
    He, Huiling
    Blondal, Thorarinn
    Geller, Frank
    Jakobsdottir, Margret
    Magnusdottir, Droplaug N.
    Matthiasdottir, Sigurborg
    Stacey, Simon N.
    Skarphedinsson, Oskar B.
    Helgadottir, Hafdis
    Li, Wei
    Nagy, Rebecca
    Aguillo, Esperanza
    Faure, Eduardo
    Prats, Enrique
    Saez, Berta
    Martinez, Mariano
    Eyjolfsson, Gudmundur I.
    Bjornsdottir, Unnur S.
    Holm, Hilma
    Kristjansson, Kristleifur
    Frigge, Michael L.
    Kristvinsson, Hoskuldur
    Gulcher, Jeffrey R.
    Jonsson, Thorvaldur
    Rafnar, Thorunn
    Hjartarsson, Hannes
    Mayordomo, Jose I.
    de la Chapelle, Albert
    Hrafnkelsson, Jon
    Thorsteinsdottir, Unnur
    Kong, Augustine
    Stefansson, Kari
    [J]. NATURE GENETICS, 2009, 41 (04) : 460 - 464